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Introduction
Mesoporous bioactive glasses (MBGs) are a new generation of bioceramics designed for bone grafting and skeletal regenerative therapies [1, 2] . These biomaterials exhibit the bone regenerative properties of bioactive glasses [3] , but significantly increased due to their high surface area and porosity [4, 5] . In addition, MBGs possess ordered mesoporous structures similar to those exhibited by pure silica mesoporous materials, which makes them excellent candidates as matrixes in drug delivery applications [6] [7] [8] .
This synergy between osteogenic properties and local drug delivery capabilities is called to play a main role in field of skeletal therapies in near future. Several studies have been carried out to evaluate the behavior of MBGs as drug delivery systems [9] , which have demonstrated that MBGs can release drugs following classical diffusion mechanism [10] . However, the real potential of MBGs remains still unknown. The possibility of supplying stimuli-responsive behavior to MBGs, in such a manner that they release the payload only when the pathological process occurs is unexplored.
From a different point of view, and in the context of on-command delivery, mesoporous silica has been used as an effective support for the development of controlled-release nanodevices because of their unique characteristics, such as high homogeneous porosity, inertness, robustness, thermal stability, and high loading capacity [11] [12] [13] [14] .
Consequently, a number of nanodevices for on-command delivery that can be triggered by target chemical [15] [16] [17] [18] [19] [20] [21] , physical [22] [23] [24] [25] [26] or biochemical stimuli [27] [28] [29] [30] [31] [32] [33] [34] have been designed recently. However these gated systems have been mainly developed in individual pure silica particles (usually nanometric) [35] , and gated functionalities in bioactive compositions for bone regenerative purposes are practically unknown [36] .
In order to explore new bone regeneration strategies, stimuli-responsive 3D macroporous scaffolds have been recently prepared by means of incorporating gated SiO 2 mesoporous nanoparticles within a polymeric matrix [37] . However, as far as we are aware, none of these systems have been designed for combining bone regenerative properties and on-command drug delivery. The biological response of MBGs can be partially tailored by controlling the supramolecular mechanisms that rules the synthesis.
For instance, we have recently demonstrated that the differentiation of pre-osteoblast toward osteoblast phenotype can be enhanced in contact with MBGs prepared with F68, a (EO) 78 -(PO) 30 -(EO) 78 triblock copolymer which acts as a structure directing agent [38] . However, the complexity to incorporate the nanogates onto multicomponent SiO 2 -CaO-P 2 O 5 systems has hindered perhaps the development of stimuli-responsive MBGs up to date. Nonetheless, the design of gated MBGs is highly appealing and might found a number of applications in advanced regenerative therapies.
Based on these concepts, it was in our aim to demonstrate the possibility of preparing stimuli-responsive MBGs, via the implementation of tailor-made gated ensembles on the surface of bioactive glasses. The final goal was to develop bioactive glasses able to regenerate bone tissue in bone defects while treating the causal pathology of such a defect, for instance bone infection or tumor extirpation. Therefore the mesopores of a selected MBG were capped with two different enzyme-responsive molecular gates based in the use of adenosine triphosphate (ATP) and ε-poly-L-lysine as caps (vide infra), which allowed controlled cargo release in the presence of alkaline phosphatase (ALP) and proteolytic enzymes, respectively. Proteolytic activity can be observed in the presence of different infectious pathogens as Escherichia coli [39, 40] , whereas high levels of serum ALP have prognostic significance of osteosarcoma scenarios [41] . We envision that such tailor-designed systems may have potential applications for the treatment of bone tissue defects commonly associated to osteomyelitis and bone tumors extirpation. hours under air atmosphere. Finally the MBG powder was gently milled and sieved, collecting the particle size fraction below 40 µm.
Materials and methods

Chemicals
Synthesis of S2
1 g of S1 was suspended in 30 mL of anhydrous acetonitrile under inert atmosphere.
Then, 1 mL (3.88 mmol) of 3-[2-(2-aminoethylamino)ethylamino]propyltrimethoxysilane (N3) was added and the mixture was stirred for 5.5 hours. Finally, the solid was filtered, washed with H 2 O repeatedly and dried under vacuum for 12 hours.
Synthesis of S3
200 mg of solid S2 were suspended in a solution of EDC 0.1 M and ATP 1.8 M, previously adjusted to pH 7 with NaOH. The suspension was stirred for 6 hours at room temperature. The resulting solid was filtered and dried under vacuum for 12 hours.
Synthesis of S4
In a typical synthesis, 1 g of S1 was suspended in 50 mL of methanol, inside a roundbottom flask under inert atmosphere. Then, an excess of 3-(triethoxysilyl)propylisocyanate (isocyanate) (1 mL, 4 mmol) was added and the final mixture was stirred for 5.5 hours at room temperature. The solid was filtered, washed with H 2 O repeatedly, and dried under vacuum for 12 hours.
Synthesis of S5
A solution of 1 g of ε-poly-L-lysine (0.2 mmol) and TEA (1.6 mL, 11.5 mmol) in 20 mL of methanol was added onto the solid S4, and the mixture was stirred for 2 hours.
Finally, the solid was filtered off and dried under vacuum.
Synthesis of S3-Ru and S5-Ru
In order to carry out the proof of concept about the functioning of ATP and ε-poly-llysine based gates, both systems were loaded with a fluorescence dye. For this purpose 2 g of S1 were suspended in a solution of 1.6 g tris(2,2'-bipyridil)ruthenium(II) chloride hexahydrate ([Ru(bpy) 3 ] 2+ dye in 70 mL of anhydrous acetonitrile in a round-bottomed flask. Then, 10 mL of acetonitrile were distilled with a dean-stark, in order to remove the possible water present in the pores of the solid. Afterwards, the mixture was stirred at room temperature during 24 hours, in order to achieve maximum loading in the pores of the MBG scaffolding. The resulting solid was then filtered and dried under vacuum for 12 hours. Subsequently, the solid was functionalized and capped as S3 and S5 respectively, as described above. Once dried, the solids were suspended in 5 mL of water and stirred in short washing, in order to remove the excess of dye remaining on the surface of the materials. The solids were filtered again and dried under vacuum for 12 hours.
Synthesis of S3-Levo and S5-Levo
In order to test the functioning of ATP and ε-poly-L-lysine based gates as on command antibiotic delivery devices, both systems were loaded with levofloxacin. For this purpose 800 mg of S1 were suspended in a solution of 400 mg (1.11 mmol) of levofloxacin in 20 mL of methanol inside a round-bottom flask under inert atmosphere.
The mixture was stirred at room temperature during 24 hours to achieve maximum loading in the pores of the MBG. Subsequently, the solution was split in two and each part was functionalized in a similar way to S3 and S5 respectively. Finally S3-Levo and S5-Levo were washed in water to remove the excess of antibiotic remaining on the surface.
Synthesis of S3-Dox
In order to test the functioning of the ATP based gate as on command antitumoral delivery devices, 30 mg of solid S2 and 6 mg of doxorubicin were suspended in 5mL of methanol and stirred for 50 hours. Then, the solid was centrifuged and dried under vacuum for 1 hour. Finally the solid was introduced in a solution of EDC 0.1 M and ATP 1.8 M previously adjusted to pH 7 with NaOH. The suspension was stirred for 6
hours at room temperature. The resulting solid was centrifuged, washed several times with water and methanol and dried under vacuum for 12 hours. Table 1 contains a summary of the synthesized solids.
Stimuli-responsive studies
Stimuli-responsive studies with S3-Ru and S5-Ru
4 mg of the S3-Ru and S5-Ru were suspended in 10 mL of water, and the pH was adjusted to 7.6 with NaOH. Both suspensions were split in two in order to study the dye release in the absence or presence of the corresponding stimuli, i.e. ALP and pronase for S3-Ru and S5-Ru, respectively. The two samples were stirred at 400 rpm and 37°C, and then several 250µL aliquots were taken for each sample at different times. These aliquots were filtered with PFTE filters (0.22 µm) to monitor the [Ru(bpy) 3 ] 2+ release (λ ex 454 nm, λ em 593 nm) by fluorescence spectroscopy
Stimuli-responsive studies with S5-Levo
4 mg of S5-Levo were suspended in 10 mL of water, and the pH was adjusted to 7.6
with NaOH. The suspension was split in two in order to study the levofloxacin release in the absence and the presence of E.coli (final concentration 10 5 cells mL -1 ). The two samples were stirred at 400 rpm and 37 °C, and then several 250µL aliquots were taken for each sample at different times. These aliquots were filtered with PFTE filters (0.22 µm) to monitor the levofloxacin release (λ ex 292 nm, λ em 494 nm) by fluorescence spectroscopy. 
Stimuli
Bioactivity assays with solids S3 and S5
Assessments of in vitro bioactivity were carried out on S3 and S5 solids. For this purpose, 40 mg of the solids were soaked into 6 mL of filtered simulated body fluid (SBF) [46] in polyethylene containers at 37 °C under sterile conditions [38] . The evolution of the solids surfaces were analyzed by Fourier transform infrared (FTIR) spectroscopy and scanning electron microscopy (SEM).
Biological assessment of the gated materials
E. coli DH5α culture conditions
For viability studies, bacteria Escherichia coli (E. coli), cell culture DH5α was used.
Bacteria cells were maintained in glycerol 15% at -80 °C. For the assays, cells were grown for 24 hours at 37 °C and under constant stirring with 5 mL of LB medium. Cells from 1 mL culture were collected by centrifugation for 30 seconds at 13000 rpm and resuspended in 1 mL of milliQ water at pH 7.6. Then a dilution of 2·10 4 cells·mL -1 was prepared, in order to achieve a final concentration of 10 4 cells·mL -1 . The same procedure was carried out for both kinetic and viability assays. poly-L-lysine) were achieved. In order to test the specificity of the gates, solid S3-Levo (capped with ATP) was submitted to the same procedure. Thereafter, S3-Dox solid was added on the seed cells at half confluence at 200µg·mL -1 concentration.In order to study the stimuli-responsive behavior of the ATP gate, ALP was added to the culture wells to simulate a scenario of ALP activity excess.
Human Osteosarcoma (HOS) cells culture test
Cell proliferation test
Cell proliferation in contact with S3 and S3-Dox was determined by the MTT method.
Samples were incubated for 4 hours at 37 °C and 5% CO 2 under dark conditions. Then, the medium was removed and 0.5 mL of isopropanol-HCl solution were added. Finally, the absorbance was measured at 460 nm.
Statistics
Statistics Data are expressed as means-standard deviations of experiments. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) version 22 software (IBM). Statistical comparisons were made by analysis of variance (ANOVA). Subsequently, post hoc analyses were carried out to correct for multiple comparisons. In all of the statistical evaluations, P< 0.05, P<0.01 were considered as statistically significant.
Results and discussion
Characterization results
The synthesis strategies developed in this work are aimed to design multifunctional bioceramics with two main features. The first one is the stimulation of bone tissue regeneration to restore the skeletal integrity in bone defects. In this sense, the material should exhibit high bioactive behavior, that is, the capability to osteointegrate with the host tissue through the formation of an apatite-like phase on its surfaces. The second function is to deliver drugs on demand to treat the causal pathology of the bone defect, for instance bone infection or extirpated bone tumors. In order to reach these goals we have designed two different on demand drug delivery systems, depicted in Scheme 1.
The first one has been designed on the basis that ATP molecules acted as capping FTIR spectroscopy was carried out after each functionalization stage, confirming the presence of the corresponding functional groups for solids S1, S2, S3, S4 and S5 (see Figure S1 in Supporting Information).
The MBG functionalization was followed by solid state NMR to confirm the successful incorporation of the different components of the gates. Figure 1 shows solid-state 29 Si single pulse (left) and cross-polarization (right) MAS NMR spectra for solids S1, S3
and S5. These experiments were used to evaluate the presence of the organosilanes linkers bonded to the MBG surface. In solid S1, single pulse spectrum shows three signals corresponding to Q n inorganic silica environment. The observed chemical shifts, the CP spectra pointing out that the liker is mainly located at the MBG surface. In the case of solid S5, the functionalization with 3-(triethoxysilyl) propylisocyanate seems to be lower, as SP spectra does not shown T n signals and only CP spectra evidenced the presence of this organosilane at the surface of S5 [42] .
Solid-state 31 P single pulse MAS NMR spectra for sample S3 were used to evaluate the local environment of P (Figure 2) . The band at 1.8 ppm is associated with inorganic Table S2 (Supporting Information).
The mesoporous structure of the different solids was confirmed by TEM (Figure 4 ). In the case of solid S1, the characteristic channels of a mesoporous ordering matrix were observed as alternate black and white stripes, evidencing the 2D hexagonal ordered mesoporous structure ( Figure 4A and 4B). The TEM images of solids S3 and S5 (figures 4C and 4D, respectively) also show ordered mesoporous arrangement, indicating that the loading and capping processes undergone by the MBG did not significantly affect the mesoporous structure.
The N 2 adsorption-desorption isotherms of S1 show a type IV curve, characteristic of mesoporous materials ( Figure 5) . The curve shows a H1 hysteresis loop indicating that mesopores have an opened at both ends cylinder morphology. Solids S3-Ru and S5-Ru exhibit isotherms corresponding to mesoporous materials with lower surface area and pore volume, as could be expected after loading with [Ru(bpy) 3 ] 2+ and subsequent capping with the ATP (solid S3-Ru) or ε-poly-L-lysine (solid S5-Ru) based gates (see Table 2 ). Solid S3-Ru shows a strong decrease of textural values respect to pristine solid S1. In fact, the hysteresis loop changes to type H2 pointing out that the mesopore morphology shifts from open cylinders towards ink-bottle morphology as a consequence of the highly effective capping with the ATP gate. On the other hand, the textural parameters of solid S5-Ru underwent a lower decrease of textural parameters.
The higher organic content of solid S3-Ru compared to S5-Ru calculated from thermogravimetry would justify the different decrease of porosity observed in these solids (see Figure S2 in Supporting Information for further details).
Kinetic studies
In order to investigate the gating properties of ATP and ε-poly-L-lysine gates, cargorelease studies were carried out with S3-Ru and S5-Ru. In a typical experiment, 2 mg of S3-Ru were suspended in water at pH 7.6 in the presence and absence of ALP.
Suspensions were stirred at 400 rpm at 37 °C for 10 hours, and at given time intervals These experiments confirm that ε-poly-L-lysine is a suitable capping system in MBG supports, which can be hydrolyzed in the presence of pronase enzyme, thus resulting in cargo release.
In vitro bioactivity tests
MBGs , which appear in the FTIR spectra when this process takes place [46, 47] . In addition the surface evolution and the changes in the Ca/P ratio was followed by SEM/EDX to confirm the in vitro formation of the newly growth apatite on the materials surface. The tests were carried out in absence and presence of the corresponding enzymatic stimuli. In absence of stimuli, the SEM micrograph does not evidence significant changes at the solid S3 surface (Figure 7A, 7B) . However, in the presence of ALP (Figure 7C 
Biological assessment of the gated materials
In order to test the stimuli-responsive properties of ATP-gated materials, the release of doxorubicin from S3-Dox solid was analyzed in the absence and presence of ALP Finally, the HOS viability was determined for longer exposure times. After 144 hours of test, the HOS viability in the presence of solid S3 remains unaltered. However, in the case of doxorubicin loaded sample (S3-Dox), a significant decrease of HOS viability was observed under both conditions, i.e. ALP presence and absence. This fact can be attributed to the MBG solubility that allows the partial release of the antitumoral drug.
However, it must be highlighted that doxorubicin release is still higher in the presence of ALP, pointing out that the stimuli-responsive behavior is present even after the partial degradation of the MBG matrix associated to the bioactive process.
In a second scenario, the MBG solid capped with ε-poly-L-lysine was loaded with the antibiotic levofloxacin (solid S5-Levo) and the selective delivery of the antibiotic in the presence of bacteria was evaluated. For this study Escherichia coli, DH5α strain, was used as model bacteria. In a first step, the amount of cargo released from S5-Levo was determined in the presence and in the absence of bacteria. As shown in Figure 10 , a limited payload delivery (less than 20% after 25 hours) was found in the absence of E.
coli, whereas a remarkable cargo delivery was found when the bacteria were present.
From these studies it was found that maximum amount of levofloxacin released from S5-Levo was of 0.322 ng of levofloxacin per mg of solid. Moreover, it was also observed that delivery of antibiotic levofloxacin was concomitant with a reduction of bacteria viability (vide infra).
The antimicrobial activity of S5-Levo was studied more in detail by carrying clonogenic cell-viability assays in which E. coli bacteria were treated with different concentrations of S5-Levo at pH 7.6. A negative assay with no bacteria was also carried out and used as control to quantify cell growth. In a typical experiment, bacteria (10 . Additionally, to demonstrate that the antibiotic effect found for S5-Levo was due to the release of levofloxacin in the presence of E. coli, similar experiments were carried out with a MBG support also capped with ε-poly-L-lysine but that did not contain levofloxacin (solid S5). This solid showed negligible toxicity against bacteria (data not shown), strongly suggesting that the delivery of antibiotic levofloxacin from S5-Levo was the responsible for bacterial death. Moreover, in a further experiment the toxicity of solid S5-Levo was compared to that of free levofloxacin and free ε-poly-L-lysine. As depicted in Figure 11 , levofloxacin and ε-poly-L-lysine showed similar toxicity to E. , respectively. This is a remarkable result that indicated that levofloxacin is seven-fold more toxic when entrapped in S5-Levo than when free.
The toxic effect observed for S5-Levo described above against E. coli can be understood keeping in mind that ε-poly-L-lysine molecules can be hydrolysed by proteolytic enzymes excreted by the bacteria [54] which would result in levofloxacin delivery. In order to demonstrate that protease activity of E. coli was the responsible of the release of levofloxacin via degradation of the ε-poly-L-lysine cap, parallel experiments were performed with solid S3-Levo. This is a MBG support loaded with the antibiotic levofloxacin and capped with the ATP gate-like ensemble described above. As the ATP gate cannot be degraded by proteases, it was expected that this solid would not be toxic for E. coli. The antimicrobial activity of solid S3-Levo was studied following a similar protocol to that described above for S5-Levo. However, in this case, no remarkable toxicity to E. coli was found after treating bacteria with S3-Levo and no levofloxacin delivery was observed.
Conclusions
In conclusion, it has been demonstrated that MBGs can be functionalized and implemented with tailored molecular gates, allowing a new application as controlled delivery device. Specifically, two different solids were prepared from a MBG selected as an inorganic support. One portion was functionalized with a triamine and capped with ATP, whereas the other portion was functionalized with isocyanates and capped with ε-poly-L-lysine. Solids following each step were correspondingly characterized, finding evidence of their correct functionalization with the tailored molecular gates.
Both molecular gated mechanisms were proved to be opened, in the presence of the corresponding enzymes (ALP and pronase, respectively), while they remained closed in the absence of the stimuli. Moreover, we have demonstrated the different bioactive behavior in both gated solids. Whereas ε-poly-L-lysine-capped system allows the formation of crystalline hydroxyapatite on their surface under any scenario, the ATPcapped system requires the opening of the molecular gate to initiate the formation of the apatite phase.
Finally, the in vitro efficiency of both gated systems was validated. The ATP-capped system responds to the presence of high levels of ALP, opening the gates and releasing doxorubicin. Higher serum ALP levels are found in patients developing osteosarcoma and our ATP-capped system has demonstrated to inhibit the HOS cells proliferation under a similar scenario. Regarding the ε-poly-L-lysine-capped system, we demonstrated that the presence of E.coli bacteria was also able to hydrolyze the ε-poly-L-lysine gate, allowing levofloxacin release. Therefore, we also tested the cytotoxic effect of the solid, and demonstrated that equitoxic concentration of the levofloxacin contained in the solid was more effective against bacteria than free levofloxacin and free ε-poly-L-lysine. We also proved that the capped solid performed no cellular damage when there was no levofloxacin inside the pores, which evidences that the cytotoxicity is totally caused by the released levofloxacin.
Thus, we have envisioned here a new approach to mesoporous gated materials, which is expected to set up innovative pathways to the treatment of bone diseases. 
